<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Arra M</submitter><funding>NIAMS NIH HHS</funding><funding>U.S. Department of Health &amp;amp; Human Services | National Institutes of Health</funding><funding>Shriners Hospitals for Children</funding><pagination>3427</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7347613</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>11(1)</volume><pubmed_abstract>The contribution of inflammation to the chronic joint disease osteoarthritis (OA) is unclear, and this lack of clarity is detrimental to efforts to identify therapeutic targets. Here we show that chondrocytes under inflammatory conditions undergo a metabolic shift that is regulated by NF-κB activation, leading to reprogramming of cell metabolism towards glycolysis and lactate dehydrogenase A (LDHA). Inflammation and metabolism can reciprocally modulate each other to regulate cartilage degradation. LDHA binds to NADH and promotes reactive oxygen species (ROS) to induce catabolic changes through stabilization of IκB-ζ, a critical pro-inflammatory mediator in chondrocytes. IκB-ζ is regulated bi-modally at the stages of transcription and protein degradation. Overall, this work highlights the f</pubmed_abstract><journal>Nature communications</journal><pubmed_title>LDHA-mediated ROS generation in chondrocytes is a potential therapeutic target for osteoarthritis.</pubmed_title><pmcid>PMC7347613</pmcid><funding_grant_id>R01 AR049192</funding_grant_id><funding_grant_id>85160</funding_grant_id><funding_grant_id>AR075860</funding_grant_id><funding_grant_id>AR057235</funding_grant_id><funding_grant_id>R01 AR068972</funding_grant_id><funding_grant_id>R01 AR064755</funding_grant_id><funding_grant_id>AR049192</funding_grant_id><funding_grant_id>AR054326</funding_grant_id><funding_grant_id>AR072623</funding_grant_id><funding_grant_id>P30 AR074992</funding_grant_id><funding_grant_id>AR068972</funding_grant_id><funding_grant_id>P30 AR057235</funding_grant_id><funding_grant_id>R01 AR075860</funding_grant_id><funding_grant_id>R01 AR054326</funding_grant_id><funding_grant_id>R01 AR072623</funding_grant_id><funding_grant_id>AR064755</funding_grant_id><pubmed_authors>Shen J</pubmed_authors><pubmed_authors>Swarnkar G</pubmed_authors><pubmed_authors>Ke K</pubmed_authors><pubmed_authors>Ying J</pubmed_authors><pubmed_authors>Arra M</pubmed_authors><pubmed_authors>Rai MF</pubmed_authors><pubmed_authors>Otero JE</pubmed_authors><pubmed_authors>Mbalaviele G</pubmed_authors><pubmed_authors>Duan X</pubmed_authors><pubmed_authors>Maruyama T</pubmed_authors><pubmed_authors>O'Keefe RJ</pubmed_authors><pubmed_authors>Abu-Amer Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>LDHA-mediated ROS generation in chondrocytes is a potential therapeutic target for osteoarthritis.</name><description>The contribution of inflammation to the chronic joint disease osteoarthritis (OA) is unclear, and this lack of clarity is detrimental to efforts to identify therapeutic targets. Here we show that chondrocytes under inflammatory conditions undergo a metabolic shift that is regulated by NF-κB activation, leading to reprogramming of cell metabolism towards glycolysis and lactate dehydrogenase A (LDHA). Inflammation and metabolism can reciprocally modulate each other to regulate cartilage degradation. LDHA binds to NADH and promotes reactive oxygen species (ROS) to induce catabolic changes through stabilization of IκB-ζ, a critical pro-inflammatory mediator in chondrocytes. IκB-ζ is regulated bi-modally at the stages of transcription and protein degradation. Overall, this work highlights the f</description><dates><release>2020-01-01T00:00:00Z</release><publication>2020 Jul</publication><modification>2026-07-16T07:12:33.953Z</modification><creation>2026-07-09T10:43:28.066Z</creation></dates><accession>S-EPMC7347613</accession><cross_references><pubmed>32647171</pubmed><doi>10.1038/s41467-020-17242-0</doi></cross_references></HashMap>